SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.685+0.3%3:55 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: mattstat who wrote (12803)7/15/2020 11:02:23 AM
From: Savant   of 12871
 
**I find it interesting that this comes out right after large funding occured..fwiw

“We should be able to get into humans in about six to eight weeks. That’s our estimate,” he said April 8 on a BioCT virtual panel ...Diwan

*The clock is running, now into overtime

Seymour...

In an interview with CNBC, Dr. Eugene Seymour, NanoViricides’ co-founder with Diwan, said those releases were not intended to increase the stock price. (**lol)

He was the CEO when those press releases were sent out

Rogues' Gallery



NanoViricides rang the opening bell of the New York Stock Exchange on Aug. 13, 2014. In the front center (left to right) are Meeta Vyas, Anil Diwan and Dr. Eugene Seymour.

CNBC

*All in my opinion
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext